Huntington's Disease (HD) is characterized by progressive motor and cognitive decline, largely driven by cortico-striatal synaptic dysfunction. Central to these processes is huntingtin (HTT) protein, which is abundantly present at the synapse. HTT regulates the synaptic vesicle cycle at presynaptic terminals and serves as a scaffold at the postsynaptic density where it modulates receptor dynamics. An expanding network of HTT-interacting proteins (HIPs), crucial for maintaining synaptic structure and function, underscores the role of HTT as a core component of synaptic integrity. This review examines the 30-year research journey that has unveiled HTT pre- and postsynaptic partners, with focus on experimentally validated interactors and their involvement in HD cortico-striatal synaptic dysfunction.

Huntingtin and its allies at the cortico-striatal synapse / C. Zuccato, A. Scolz, R. Iennaco. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - 17:1(2026 Mar 27), pp. 412.1-412.15. [10.1038/s41419-026-08584-6]

Huntingtin and its allies at the cortico-striatal synapse

C. Zuccato
Primo
;
A. Scolz;R. Iennaco
Ultimo
2026

Abstract

Huntington's Disease (HD) is characterized by progressive motor and cognitive decline, largely driven by cortico-striatal synaptic dysfunction. Central to these processes is huntingtin (HTT) protein, which is abundantly present at the synapse. HTT regulates the synaptic vesicle cycle at presynaptic terminals and serves as a scaffold at the postsynaptic density where it modulates receptor dynamics. An expanding network of HTT-interacting proteins (HIPs), crucial for maintaining synaptic structure and function, underscores the role of HTT as a core component of synaptic integrity. This review examines the 30-year research journey that has unveiled HTT pre- and postsynaptic partners, with focus on experimentally validated interactors and their involvement in HD cortico-striatal synaptic dysfunction.
Settore BIOS-11/A - Farmacologia
   Role of ADAM10 in Huntinton Disease
   FONDAZIONE TELETHON ETS
   GGP13053

   Modulazione della funzione della proteina ADAM10 per correggere la disfunzione nelle cellule nervose coinvolte nella malattia di Huntington
   FONDAZIONE TELETHON ETS
   GGP20067

   ADAM10 nella Malattia di Huntington: studio molecolare e funzionale della sinapsi
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   20128XWKTX_001
27-mar-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
Zuccato_CDD_2026.pdf

accesso aperto

Descrizione: pdf review
Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 2.44 MB
Formato Adobe PDF
2.44 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1246204
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact